A research of the brain function activity change after intranasal oxytocin administration

A research of the brain function activity change after intranasal oxytocin administration - brain function activity change by medication

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004966

Enrollment

Registered

2011-01-26

Start date

2011-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with neuropsychiatric disorders

Interventions

single intranasal oxytocin administration single intranasal placebo administration

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with neuropsychiatric disorders and normal controls

Exclusion criteria

Exclusion criteria: Participants were excluded if they had a history of major medical or neurological illness including epilepsy, significant head trauma, or a lifetime history of alcohol or drug dependence.

Design outcomes

Primary

Measure	Time frame
magnetic resonance imaging (MRI) near-infrared spectroscopy (NIRS) eye-tracking BIOPAC blood sample	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026